![11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one](https://static.cymitquimica.com/products/3D/img/FXB84377.png "Click to enlarge")
11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
CAS: 1180843-77-9
Ref. 3D-FXB84377
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one (Asenapine maleate) is a pharmaceutical preparation that contains the active ingredient Asenapine. It is used to treat mental disorders and psychotic symptoms such as delusions or hallucinations. Asenapine was developed by Novartis Pharmaceuticals Corporation and has been marketed since 1999. It is administered orally as a tablet or liquid and can be taken with or without food. Asenapine's main mechanism of action is through its antagonistic effect on dopamine receptors in the brain which leads to a decrease in dopaminergic activity. The drug also has an antagonist effect on serotonin receptors and adrenergic alpha 1 receptors. Asenapine has been shown to be more efficient than other antipsychotics such
